PSMB9 and Hodgkins lymphoma: The LMP2 response might be necessary to prevent and treat EBV associated malignancies with reduced viral antigen expression like Hodgkin's lymphoma, inhibiting the outgrowth of transformed EBV+ germinal center B cells that express this protein.